OCT-A, developed by Optovue, marks ten years of innovation
Since its introduction in 2014, OCT-A (Optical Coherence Tomography- Angiography) has revolutionized ophthalmic imaging. This innovative technology has brought significant advances in diagnostics and management of ocular pathologies, offering clinicians and researchers new perspectives on retinal vascularization. Optovue, now by Visionix, is the pioneer of OCT-A and celebrates ten years of this technology. We have kept our promise to become the standard in OCT-A.
Read article